TY - JOUR T1 - Evaluation of participation and performance indicators in a breast cancer screening program in Saudi Arabia JF - Saudi Medical Journal JO - Saudi Med J SP - 1260 LP - 1264 DO - 10.15537/smj.2022.43.11.20220269 VL - 43 IS - 11 AU - Yasser M. Alatawi AU - Hala A. Alshomrani AU - Sara M. Baeshen AU - Hayat H. Alkhamisi AU - Roaa M. Almazrui AU - Mohammed S. Alghamdi AU - Sara M. Bugshan AU - Tarik K. Alafif AU - Hussam A. Hijazi AU - Jawaher R. Alahmadi AU - Sawsan A. Ashoor AU - Ahmad M. Alamri AU - Faris Alkhilaiwi Y1 - 2022/11/01 UR - http://smj.org.sa/content/43/11/1260.abstract N2 - Objectives: To evaluate early performance indicators for breast cancer screening at the King Abdulaziz University Hospital in Saudi Arabia.Methods: This study retrospectively evaluated data from women who underwent their first breast cancer screening program in Jeddah, Saudi Arabia between 2012 and 2019. Data on screening results were used to estimate performance indicators and generate descriptive statistics.Results: Of the 16000 women invited from 2012 to 2019, a total of 1911 (11.9%) participated. The majority of women (68.8%) were between 40 and 55 years old. Based on the screening process results, 26.6%, 40.1%, 9.7%, 1.3%, 0.7%, and 5.2% of women had BI-RADS scores of R1, R2, R3, R4, R5, and R0 respectively. The remaining 16.3% did not have mammogram records. The recall rate, or the percentage of women who underwent further evaluation, was 19.9%; 18.9% underwent a biopsy procedure. In addition, 1.6% of women had cancer screen-detected, although only 0.7% were diagnosed with breast cancer.Conclusion: In light of the low participation and high recall rates, it is essential that the screening program utilizes performance indicators to optimize resource utilization and ensure the quality of the service provided. Additionally, a national framework and standardized performance indicators could mitigate this problem for other cancer screening programs. ER -